See the sequence
Keep symptoms, tests, interventions, and responses connected to dates and sources.
Timeline editing · In previewRAGMD · Clinical evidence in context
A clinical question deserves more than an isolated answer. Explore the evidence, inspect where it applies, and bring the story over time into view.
Workspace preview · Synthetic cases only
The journey
Baseline severity not recorded
Adherence needs clarification
Response reported at follow-up
Current question
DraftClarify the change, compare possibilities, and identify what evidence would apply.
Comparable outcome measure and treatment details are missing.
No diagnosis or recommendation generated. Preview entries are clinician authored.
Available today
Search evidence without entering patient information.
From question to review
Evidence research is available now. The case workspace lets you explore the next experience with synthetic information.
Keep symptoms, tests, interventions, and responses connected to dates and sources.
Timeline editing · In previewExplore published research. In the preview, attach sources and record applicability limits.
Evidence search · Available todayDocument alternatives, evidence for and against, and information still needed.
Clinician-authored comparison · In previewCreate a brief, save a session baseline, inspect changes, and export your work.
Session versions & export · In previewInspect before you trust
Source findings, patient context, and clinician decisions should remain distinct.
Explore our methodologyOriginal sourcesOpen the underlying research and assess support.
Applicability limitsRecord who was studied and what remains unknown.
Visible review statusA draft remains a draft until reviewed.
Live evidence preview
Bottom line
Large randomized data (including TRAVERSE) do not show a significant increase in major adverse cardiovascular events with testosterone therapy in hypogonadal men over median follow-up of roughly three years. Older observational studies conflict, and absolute risk depends on baseline cardiovascular disease, formulation, and monitoring.
Testosterone replacement therapy and cardiovascular disease.
Validated effect estimates in the analyzed set include odds ratio 1.07; HR 1. Statistical significance is not the same as clinical importance.
Testosterone therapy should be individualized with cardiovascular risk assessment and monitoring rather than categorically avoided.
Evidence confidence
Evidence Confidence
HighMultiple high-quality studies directly address this question, with generally consistent findings.
Published evidence synthesis
Explore the full evidence →Topic discovery
Explore maintained evidence by clinical domain — with question counts where published.
Testosterone therapy, estradiol in men, monitoring controversies, and TRT safety questions.
12 maintained questions
Mixed confidence across questions
Erectile dysfunction, PDE5 inhibitors, testosterone and sexual function, and premature ejaculation evidence.
10 maintained questions
Mostly high-confidence questions
HRT safety, perimenopause, vasomotor symptoms, GSM, bone health, and women's hormone therapy.
22 maintained questions
Mixed confidence across questions
Hypothyroidism treatment targets, combination therapy, desiccated thyroid, and thyroid-metabolic questions.
6 maintained questions
Mixed confidence across questions
Lipids, statins, ApoB, blood pressure, and cardiovascular prevention evidence.
10 maintained questions
Mixed confidence across questions
GLP-1 outcomes, muscle preservation, weight regain, and incretin safety questions.
7 maintained questions
Mixed confidence across questions
Supplementation, aging-related hormones, and preventive medicine evidence reviews.
4 maintained questions
Mixed confidence across questions
RAGMD Pro from $99/month after a 7-day free trial. Cancel anytime.
How it works
Ask a question. RAGMD finds relevant evidence, determines which studies matter most, surfaces credible disagreement, and explains Evidence Confidence.
See How It WorksPubMed AI
RAGMD searches your library and PubMed, weighs which trials matter, and returns PMID-linked evidence you can share.
PubMed AI for physiciansHormone & metabolic medicine for clinicians — not RadMD radiology prior auth.